4 Topic Commentaries
Glaucoma Trials Tracker
-
Jella An, MD
Glaucoma
•Johns Hopkins Medicine, Wilmer Eye Institute
SourceClinical trials are very important because they are how you innovate and move the field forward, eventually changing the practice pattern for better.
-
Hugh Beckman, MD
Ophthalmology
•Sinai Hospital of Detroit
SourceOur results suggest that initial treatment with laser is at least as effective as an initial treatment with eyedrops.
-
Carl Kupfer, MD
Ophthalmology
•National Eye Institute (NIH)
Sourcethe disease is a long-term, chronic illness that must be controlled over the patient’s lifetime in order to save vision.
-
Arthur J. Sit, MD, MS
Ophthalmology
•Mayo Clinic
SourceThrough advanced technologies and extensive resources, we're committed to innovating research to better understand and treat glaucoma.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







